✦ LIBER ✦

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) versus Bortezomib-Thalidomide-Dexamethasone (VTD) -based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta-analysis

✍ Scribed by Leiba, Merav; Kedmi, Meirav; Duek, Adrian; Freidman, Tzachi; Weiss, Mia; Leiba, Ronit; Nagler, Arnon; Avigdor, Abraham

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib-Cyclophosphamide-Dexamethason

✍ Leiba, Merav; Kedmi, Meirav; Duek, Adrian; Freidman, Tzachi; Weiss, Mia; Leiba, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Consolidation Therapy with Bortezomib/Le

✍ Fonseca, Rafael; Rajkumar, S. Vincent 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 96 KB

(Bortezomib plus lenalidomide/thalidomid

✍ Wang, Anyou; Duan, Qiaohong; Liu, Xin; Ding, Kaiyang; Han, Yongsheng; Zhu, Weibo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 777 KB

Sequential vincristine, adriamycin, dexa

✍ Hye Jin Kim; Sung-Soo Yoon; Dong Soon Lee; Sang Kyun Sohn; Hyeon Seok Eom; Jung 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 184 KB

Cost-Effectiveness of Induction Treatmen

✍ van Beurden-Tan, C.; Rosiñol, L.; Diels, J.; Wirth, D.; Chirita, O.; Lahuerta, J 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Bortezomib with thalidomide plus dexamet

✍ Michele Cavo; Paola Tacchetti; Francesca Patriarca; Maria Teresa Petrucci; Lucia 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 276 KB